At the time of writing, Artiva Biotherapeutics Inc [ARTV] stock is trading at $12.46, up 6.22%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ARTV shares have gain 25.10% over the last week, with a monthly amount glided 23.73%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Artiva Biotherapeutics Inc [NASDAQ: ARTV] stock has seen the most recent analyst activity on August 13, 2024, when Wedbush initiated its Outperform rating and assigned the stock a price target of $18. On August 13, 2024, Needham initiated with a Buy rating and assigned a price target of $23 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $21 on August 13, 2024. Cantor Fitzgerald initiated its recommendation with a Overweight and recommended $23 as its price target on August 13, 2024.
For the past year, the stock price of Artiva Biotherapeutics Inc fluctuated between $9.71 and $16.00. Currently, Wall Street analysts expect the stock to reach $20.5 within the next 12 months. Artiva Biotherapeutics Inc [NASDAQ: ARTV] shares were valued at $12.46 at the most recent close of the market. An investor can expect a potential return of 64.53% based on the average ARTV price forecast.
Analyzing the ARTV fundamentals
Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -122.24%, Pretax Profit Margin comes in at -113.55%, and Net Profit Margin reading is -123.36%. To continue investigating profitability, this company’s Return on Assets is posted at -0.41, Equity is 0.17 and Total Capital is -0.47. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-0.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 11.61 points at the first support level, and at 10.75 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.96, and for the 2nd resistance point, it is at 13.45.
Ratios To Look Out For
It is important to note that Artiva Biotherapeutics Inc [NASDAQ:ARTV] has a current ratio of 4.59. Further, the Quick Ratio stands at 4.59, while the Cash Ratio is 3.16.
Transactions by insiders
Recent insider trading involved RA CAPITAL MANAGEMENT, L.P., Director, that happened on Jul 22 ’24 when 8.33 million shares were purchased. 10% Owner, 5AM Partners VI, LLC completed a deal on Jul 22 ’24 to buy 0.83 million shares. Meanwhile, 10% Owner venBio Global Strategic Fund I bought 0.42 million shares on Jul 22 ’24.
